Boston Scientific, Surgi-Vision to Develop Cardiac Devices

Boston Scientific Corp. and Surgi-Vision Inc. of Baltimore, Md., announced a deal to license and develop magnetic resonance imaging (MRI)-safe technology for implantable cardiac devices. The companies will jointly develop a commercial application of Surgi-Vision's technology. They made a separate licensing and development agreement, in the area of neuromodulation, in December 2005.





LATEST NEWS

• HOLOEYE Partners with Fraunhofer IPMS on Microdisplay
  Nov 22, 2024
• PI Expands German Production Site: Week in Brief: 11/22/24
  Nov 22, 2024
• Lightsynq Emerges from Stealth with $18M Series A
  Nov 21, 2024
• REMBRANDT Project Collaborators to Advance Microwave Photonics
  Nov 21, 2024
• Quasicrystals Create Light Vortices to Transmit More Data with Fiber Optics
  Nov 21, 2024
• Study Finds Laser Light Can Cast a Shadow
  Nov 20, 2024
• Lumicell Adds CEO: People in the News: 11/20/24
  Nov 20, 2024
• AeroVironment to Acquire BlueHalo in $4.1B Transaction
  Nov 20, 2024